Showing results (581-590 of 6,499) with videos related to

Sort By:
Pageof 650
Cancer Immunology, Immunotherapy : CII|January 1, 1987
Effects of L2C leukemia on macrophage-mediated responsesD P Collins
Cancer Immunology, Immunotherapy : CII|January 25, 2017
Inclusion of BLIMP-1+ effector regulatory T cells improves the Immunoscore in a cohort of New Zealand colorectal cancer patients: a pilot studyKirsten A Ward-Hartstonge, John L McCall, Timothy R McCulloch, et al.
Cancer Immunology, Immunotherapy : CII|January 12, 2017
Synergistic effects of host B7-H4 deficiency and gemcitabine treatment on tumor regression and anti-tumor T cell immunity in a mouse modelJoanne Leung, Philippe St-Onge, John Stagg, et al.
Cancer Immunology, Immunotherapy : CII|January 22, 2017
Immunosuppressive myeloid-derived suppressor cells are increased in splenocytes from cancer patientsKimberly R Jordan, Puja Kapoor, Eric Spongberg, et al.
Cancer Immunology, Immunotherapy : CII|April 7, 2019
Expression profiling of immune inhibitory Siglecs and their ligands in patients with gliomaKim C M Santegoets, Paul R Gielen, Christian Büll, et al.
Cancer Immunology, Immunotherapy : CII|October 19, 2018
The expression of MHC class II molecules on murine breast tumors delays T-cell exhaustion, expands the T-cell repertoire, and slows tumor growthTyler R McCaw, Mei Li, Dmytro Starenki, et al.
Cancer Immunology, Immunotherapy : CII|February 18, 2014
ImmTAC-redirected tumour cell killing induces and potentiates antigen cross-presentation by dendritic cellsGiovanna Bossi, Sandrine Buisson, Joanne Oates, et al.
Cancer Immunology, Immunotherapy : CII|April 15, 2017
Can local radiotherapy and IL-12 synergise to overcome the immunosuppressive tumor microenvironment and allow "in situ tumor vaccination"?Gaël Deplanque, Keyvan Shabafrouz, Michel Obeid
Cancer Immunology, Immunotherapy : CII|April 7, 2017
CCR5 in recruitment and activation of myeloid-derived suppressor cells in melanomaViktor Umansky, Carolin Blattner, Christoffer Gebhardt, et al.
Pageof 650